Glycobiology Advance Access published online on September 29, 2004
Glycobiology, doi:10.1093/glycob/cwh158
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Medical Biochemistry, Göteborg University, 413 90 Gothenburg, Sweden
* To whom correspondence should be addressed. E-mail: gunnar.hansson{at}medkem.gu.se.
A recombinant mucin O-glycosylation reporter protein, containing 1.7 tandem repeats (TR) from the transmembrane mucin MUC1, was constructed. The reporter protein, MUC1(1.7TR)-IgG2a, was produced in CHO-K1 cells to study the glycosylation of the MUC1 TR and the in vivo role of polypeptide-GalNAc-T4 glycosyltransferase. N-terminal sequencing of MUC1(1.7TR)-IgG2a showed that all five potential O-glycosylation sites within the TR were used, with an average density of 4.5 glycans per repeat. The least occupied site was Thr in the PDTR motif where 75 % of the molecules were glycosylated, compared to 88 - 97 % at the other sites. This glycan density was confirmed by an alternative LC-MS based approach. The O-linked oligosaccharides were released from MUC1(1.7TR)-IgG2a and analyzed by nano-LC-MS and LC-MS/MS. Four oligosaccharides were present, NeuAc
Revised September 21, 2004
Accepted September 22, 2004
ORIGINAL ARTICLES
A MUC1 tandem repeat reporter protein produced in CHO-K1 cells has sialylated core 1 O-glycans and becomes more densely glycosylated if co-expressed with polypeptide-GalNAc-T4 transferase
2 Cancer Research UK Breast Cancer Biology, Guy's Hospital, London SE1 9RT, UK
![]()
Abstract
2-3Gal
1-3GalNAcol, NeuAc
2-3Gal
1-3(NeuAc
2-6)GalNAcol, Gal
1-3(NeuAc
2-6)GalNAcol and Gal
1-3GalNAcol, the two first being most abundant. Co-expression of the human polypeptide-GalNAc-T4 transferase with MUC1(1.7TR)-IgG2a increased the glycan occupancy at Thr in PDTR, Ser in VTSA and Ser in GSTA, supporting the function of GalNAc-T4 proposed from previous in vitro studies. The expression of GalNAc-T4 with a mutation in the first lectin domain (
) had no glycosylation effect on PDTR and GSTA, but surprisingly gave a dominant negative effect with a decreased glycosylation to around 50% at the Ser in VTSA. The results show that introduction of glycosyltransferases can specifically alter the sites for O-glycosylation in vivo.![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. Sihlbom, I. van Dijk Hard, M. E Lidell, T. Noll, G. C Hansson, and M. Backstrom Localization of O-glycans in MUC1 glycoproteins using electron-capture dissociation fragmentation mass spectrometry Glycobiology, April 1, 2009; 19(4): 375 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Holgersson and J. Lofling Glycosyltransferases involved in type 1 chain and Lewis antigen biosynthesis exhibit glycan and core chain specificity Glycobiology, July 1, 2006; 16(7): 584 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sewell, M. Backstrom, M. Dalziel, S. Gschmeissner, H. Karlsson, T. Noll, J. Gatgens, H. Clausen, G. C. Hansson, J. Burchell, et al. The ST6GalNAc-I Sialyltransferase Localizes throughout the Golgi and Is Responsible for the Synthesis of the Tumor-associated Sialyl-Tn O-Glycan in Human Breast Cancer J. Biol. Chem., February 10, 2006; 281(6): 3586 - 3594. [Abstract] [Full Text] [PDF] |
||||

